The Latest Breaking News from Merck

The Dow Jones Industrial Average dropped 225 points Thursday on a hot CPI inflation report. Nvidia stock reversed from more record highs.

The Dow Jones rose Wednesday, as Wall Street awaits Thursday's CPI data. GS stock was downgraded, while bitcoin stock Coinbase fell.

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

The Dow Jones hit a record high while the S&P 500, Nasdaq and Russell 2000 set 2023 highs as the Fed signaled multiple rate cuts next year.

The Dow Jones index reached another high but the market weakened in afternoon trading. CAT stock jumped.

Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.

The Dow Jones rallied as Fed Chair Powell and the FOMC served up good news. Tesla stock rose despite a recall while Netflix is near an entry.